Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer.
Saved in:
| Title: | Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi) |
|---|---|
| Authors: | Bao, Guangfa1 (AUTHOR), Wang, Ziqiang1 (AUTHOR), Liu, Luoxia1 (AUTHOR), Zhang, Buchuan1 (AUTHOR), Song, Shuang1 (AUTHOR), Wang, Dongdong1 (AUTHOR), Cheng, Siyuan1 (AUTHOR), Moon, Eu-Song2 (AUTHOR), Roesch, Frank2 (AUTHOR), Zhao, Jun1,3,4 (AUTHOR), Yu, Bo1 (AUTHOR), Zhu, Xiaohua1 (AUTHOR) evazhu@vip.sina.com |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Jul2024, Vol. 51 Issue 9, p2744-2757. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
